Once thought to exist only within cells, RNA is now known to be exported from cells and play a role in newly discovered mechanisms of cell-to-cell communication. The Common Fund’s Extracellular RNA Communication (ERC) program aims to discover fundamental biological principles about the mechanisms of extracellular RNA (exRNA) generation, secretion, and transport; to identify and develop a catalogue of exRNA in normal human body fluids; and to investigate the potential for using exRNAs as therapeutic molecules or biomarkers of disease.
Insights into Potential exRNA Biomarkers for Breast Cancer
Researchers supported by the Common Fund's Extracellular RNA Communication program are gaining new insight into the potential for some types of extracellular RNA called microRNA (miRNA) to influence cancer progression.
Extracellular RNA Researcher Discovers "Treasure in Saliva"
Extracellular RNA research is laying the foundation for using exRNA in saliva to diagnose a variety of diseases, such as cancer, diabetes, autoimmune disorders, and potentially many more.
Extracellular RNA Shows Promise in Treating Multiple Sclerosis and Other Neurological Conditions
Dr. Richard Kraig and colleagues are exploring how extracellular microRNAs could be used as novel therapeutic for multiple sclerosis and other demyelinating diseases.
Extracellular RNA Found in Blood May Reveal Hidden Heart Injury
Dr. Thomas Tuschl and colleagues find microRNAs in blood that may reveal damage to the heart.
ExRNA Research Portal Launched!
The ExRNA Communication Consortium has launched the ExRNA Research Portal. This website contains information about the program, funded research, publications, resources, upcoming events, and a blog about the latest advances in exRNA research. Visit this site at exrna.org , and be sure to check back often as new content is added!